ABVC BioPharma Receives $3.175 Million Investment From The Lind Partners to Continue Clinical Trials
23 févr. 2023 16h16 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...